Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1127422

Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients


Buljubasic, Dunja; Drenjancevic, Ines; Kibel, Aleksandar; Zibar, Lada; Vizjak, Vedrana; Mandic, Sanja; Bacun, Tatjana
Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients // Arterial Hypertension, 25 (2021), 1; 15-21 doi:10.5603/ah.a2021.0003 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1127422 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients

Autori
Buljubasic, Dunja ; Drenjancevic, Ines ; Kibel, Aleksandar ; Zibar, Lada ; Vizjak, Vedrana ; Mandic, Sanja ; Bacun, Tatjana

Izvornik
Arterial Hypertension (2449-6170) 25 (2021), 1; 15-21

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
arterial hypertension ; overweight ; myeloperoxidase ; high sensitivity C-reactive protein ; inflammation ; biomarker

Sažetak
Background: Low-grade inflammation mediates the relation between overweight and the development of cardiovascular diseases. The study aimed to examine if myeloperoxidase (MPO) and hsCRP (high-sensitivity C-reactive protein) in overweight hypertensive patients can be used as biomarkers of endothelial and leukocyte activation. Material and methods: Seventy-five subjects were included in the study ; 38 had essential arterial hypertension (AH) and 37 were normotensive controls (NC), subsequently divided into overweight (OW ; BMI ≥ 25 kg/m2) and normal weight subgroups (NW ; BMI < 25 kg/m2). Body mass index (BMI), inflammatory markers concentrations, association of MPO and hsCRP with AH and/or overweight were assessed. Results: AH patients had higher MPO (median 132.5 pmol/L, IQR: 53.8–691.9) (p < 0.001), while hsCRP did not significantly differ compared to normotensive controls (NC). NW-AH patients had higher MPO (p = 0.02) than normotensive NW patients. MPO was similar between normotensive patients OW and NW, while hsCRP concentration was significantly higher in the OW (median 1.85 mg/L, IQR: 0.47–7.19) (p = 0.01) compared to NW. OW-AH patients had significantly higher MPO (median 137.4 pmol/L, IQR: 53.80–703.4) (p = 0.002) compared to normotensive NW and OW (p < 0.001) patients, likely reflecting neutrophilic activation in hypertension. Additionaly, OW-AH patients had significantly higher hsCRP (median 1.71 mg/L, IQR: 0.22–14) (p = 0.005) than normotensive NW patients. hsCRP significantly positively correlated with BMI in both AH (r = 0.41, p = 0.009) and NC groups (r = 0.38, p = 0.01), while MPO did not correlate, supporting inflammation in OW, particularly in OW with AH. Conclusions: All together, the results suggest that inflammation may mediate mutual association of AH and OW, suggesting MPO as inflammatory biomarker for AH and hsCRP for overweight.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek

Citiraj ovu publikaciju

Buljubasic, Dunja; Drenjancevic, Ines; Kibel, Aleksandar; Zibar, Lada; Vizjak, Vedrana; Mandic, Sanja; Bacun, Tatjana
Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients // Arterial Hypertension, 25 (2021), 1; 15-21 doi:10.5603/ah.a2021.0003 (međunarodna recenzija, članak, znanstveni)
Buljubasic, D., Drenjancevic, I., Kibel, A., Zibar, L., Vizjak, V., Mandic, S. & Bacun, T. (2021) Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients. Arterial Hypertension, 25 (1), 15-21 doi:10.5603/ah.a2021.0003.
@article{article, year = {2021}, pages = {15-21}, DOI = {10.5603/ah.a2021.0003}, keywords = {arterial hypertension, overweight, myeloperoxidase, high sensitivity C-reactive protein, inflammation, biomarker}, journal = {Arterial Hypertension}, doi = {10.5603/ah.a2021.0003}, volume = {25}, number = {1}, issn = {2449-6170}, title = {Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients}, keyword = {arterial hypertension, overweight, myeloperoxidase, high sensitivity C-reactive protein, inflammation, biomarker} }
@article{article, year = {2021}, pages = {15-21}, DOI = {10.5603/ah.a2021.0003}, keywords = {arterial hypertension, overweight, myeloperoxidase, high sensitivity C-reactive protein, inflammation, biomarker}, journal = {Arterial Hypertension}, doi = {10.5603/ah.a2021.0003}, volume = {25}, number = {1}, issn = {2449-6170}, title = {Myeloperoxidase (MPO) and high sensitivity C-reactive protein (hsCRP) as inflammatory biomarkers of endothelial and leukocyte activation in overweight hypertensive patients}, keyword = {arterial hypertension, overweight, myeloperoxidase, high sensitivity C-reactive protein, inflammation, biomarker} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Emerging Sources Citation Index (ESCI)
  • Scopus


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font